What is he best known for?
The fields of study he is best known for:
- Enzyme
- Cancer
- Biochemistry
His primary scientific interests are in Drug delivery, Nanotechnology, Nanoparticle, Porous silicon and Drug carrier.
His Drug delivery study incorporates themes from Biodistribution, Biocompatibility, Controlled release, Biomedical engineering and Drug.
His work on Hydrophobin expands to the thematically related Nanotechnology.
His Nanoparticle study combines topics in areas such as In vitro, Cytotoxicity, Nanocomposite, Conjugated system and Biophysics.
His Porous silicon research includes elements of Cancer cell, Dextran and Cancer immunotherapy.
Hélder A. Santos interconnects Tissue engineering, Bioanalysis and Biopolymer in the investigation of issues within Drug carrier.
His most cited work include:
- Biocompatibility of Thermally Hydrocarbonized Porous Silicon Nanoparticles and their Biodistribution in Rats (241 citations)
- Properties and chemical modifications of lignin: Towards lignin-based nanomaterials for biomedical applications (167 citations)
- Applications of bacterial cellulose in food, cosmetics and drug delivery (147 citations)
What are the main themes of his work throughout his whole career to date?
His primary areas of investigation include Nanotechnology, Drug delivery, Nanoparticle, Porous silicon and Biocompatibility.
In his study, which falls under the umbrella issue of Nanotechnology, Silicon is strongly linked to Mesoporous material.
His work in Drug delivery addresses subjects such as Biophysics, which are connected to disciplines such as Membrane.
His biological study spans a wide range of topics, including Biodistribution, Nanocomposite, Surface modification and Controlled release.
His Microfluidics research integrates issues from Polymeric nanoparticles and Dispersity.
His study on Drug is covered under Pharmacology.
He most often published in these fields:
- Nanotechnology (42.17%)
- Drug delivery (41.41%)
- Nanoparticle (32.07%)
What were the highlights of his more recent work (between 2019-2021)?
- Drug delivery (41.41%)
- Nanoparticle (32.07%)
- Nanotechnology (42.17%)
In recent papers he was focusing on the following fields of study:
Hélder A. Santos spends much of his time researching Drug delivery, Nanoparticle, Nanotechnology, Nanomedicine and Cancer therapy.
His study of Nanocarriers is a part of Drug delivery.
His Nanoparticle research incorporates elements of Melanin, Microfluidics, Porous silicon and Biomedical engineering.
His Photothermal therapy study in the realm of Nanotechnology connects with subjects such as Fabrication.
His Nanomedicine study incorporates themes from Dextran, Targeted drug delivery and Dosage form.
His studies deal with areas such as Wound healing and Gelatin as well as Biophysics.
Between 2019 and 2021, his most popular works were:
- The versatile biomedical applications of bismuth-based nanoparticles and composites: therapeutic, diagnostic, biosensing, and regenerative properties (52 citations)
- The solid progress of nanomedicine (35 citations)
- Advanced liposome-loaded scaffolds for therapeutic and tissue engineering applications (25 citations)
In his most recent research, the most cited papers focused on:
- Enzyme
- Cancer
- Biochemistry
Hélder A. Santos mainly investigates Drug delivery, Biocompatibility, Photothermal therapy, Nanoparticle and Cancer therapy.
Hélder A. Santos studies Drug delivery, namely Targeted drug delivery.
His research integrates issues of Controlled release, Nanomedicine and Nanocarriers in his study of Biocompatibility.
Photothermal therapy is a subfield of Nanotechnology that Hélder A. Santos investigates.
Hélder A. Santos does research in Nanotechnology, focusing on Nanomaterials specifically.
The Polymeric nanoparticles research Hélder A. Santos does as part of his general Nanoparticle study is frequently linked to other disciplines of science, such as Fabrication, therefore creating a link between diverse domains of science.
This overview was generated by a machine learning system which analysed the scientist’s
body of work. If you have any feedback, you can
contact us
here.
